Patents for A61P 39 - General protective or antinoxious agents (19,019)
10/1997
10/01/1997EP0797994A2 Use of one or more 5-HT2 receptor antagonists in the manufacture of a medicament for treating the symptoms of venomous bites and stings
10/01/1997EP0797442A1 Treatment of optic neuritis
10/01/1997CN1161041A Heterocycle-condensed morphinoid derivatives
09/1997
09/30/1997US5672335 Administering to enhance contrast in computer tomography
09/25/1997WO1997034856A1 Novel pyruvate compounds and methods for use thereof
09/25/1997CA2249437A1 Novel pyruvate compounds and methods for use thereof
09/24/1997EP0796623A2 Pharmaceutical preparation for the treatment of blood coagulation disorders
09/24/1997CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular.
09/24/1997CN1159922A Senility-proof health medicine
09/23/1997US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders
09/20/1997CA2200394A1 A pharmaceutical preparation for treating blood coagulation disorders
09/18/1997WO1997033877A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
09/18/1997WO1997033594A1 Methods of using emu oil and active fractions thereof as an insect repellent
09/18/1997WO1997033572A1 Method for preventing and treating peripheral neurophathy by administering selegiline
09/18/1997WO1997020569A3 Bioartificial devices and cellular matrices therefor
09/18/1997CA2249011A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
09/17/1997EP0794939A1 Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods of preparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions
09/17/1997EP0794938A1 Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy
09/17/1997EP0794799A2 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography
09/12/1997WO1997032893A1 Purification method
09/12/1997WO1997032585A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
09/12/1997CA2238029A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
09/10/1997CN1158725A Use of 8,9-dehydroestrone as antioxidant
09/04/1997WO1997031654A1 Nitric oxide donors capable of reducing toxicity from drugs
09/02/1997US5663334 Process for preparing pyrimidyl imidazoles
08/1997
08/28/1997WO1997030720A1 Method of producing an enterosorbent
08/28/1997WO1997009297A3 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
08/27/1997EP0791056A2 Lipid-splitting enzyme
08/19/1997US5658913 Thiopyrazine derivatives; enzyme inhibitor of phase 1 reaction to prevent the formation of activated toxic intermediate metabolites and induce phase ll conjugation reactions to promote excretion of toxics
08/19/1997US5658568 Cytotoxic drug therapy
08/14/1997WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a)
08/13/1997EP0788503A1 Novel quinoxalindione derivatives, their production and use in medicaments
08/12/1997US5656647 Administering; useful in x-ray therapy, exposure to nuclear radition and anticarcinogenic agents
08/12/1997US5656618 Use of an α-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained
08/07/1997DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents
08/06/1997EP0786987A1 Enterogenin pharmaceutical form
08/06/1997CN1156447A 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals
08/05/1997US5653998 With short-chain fatty acid stabilizers for active compounds from the dihydropyridines group
07/1997
07/31/1997WO1997026903A1 Microencapsulated genetically engineered microorganisms for clinical application
07/31/1997WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration
07/30/1997EP0785933A1 Indole derivatives as 5ht1-like agonists
07/30/1997EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
07/30/1997CN1155886A Salts of an anti-migraine indole derivative
07/29/1997US5652259 Administering 3-aroyl-2-arylbenzo(b)thiophene derivatives
07/29/1997US5652243 Modulating cellular response
07/23/1997EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination
07/23/1997CN1155285A New 3-substituted 3H-2,3-benzodiazepine derivatives, their preparation and use as medicaments
07/17/1997WO1997025305A1 Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
07/17/1997WO1997025046A1 Novel substituted imidazole compounds
07/16/1997EP0583281B1 Antivenom immunesera
07/15/1997US5648343 Method for treating LPS-mediated disorders
07/15/1997US5648087 Phencyclidine anesthetic
07/10/1997DE19601060A1 Neue monofunktionalisierte EDTA-, DTPA- und TTHA-Derivate und deren Verwendung in der medizinischen Diagnostik und Therapie New monofunctionalized EDTA, DTPA and TTHA derivatives and their use in medical diagnostics and therapy
07/08/1997US5646149 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
07/03/1997WO1997023482A1 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives
07/02/1997EP0781554A1 Hydroxyl radical scavenger
07/02/1997EP0781285A1 Fused indole and quinoxaline derivatives, their preparation and use
07/02/1997EP0781284A1 Indole-2,3-dione-3-oxime derivatives, their preparation and use
07/02/1997CN1153176A Stable crystalline tetrahydrofolic acid salts
07/02/1997CN1153061A 三湘神茶 God Sunshine Tea
06/1997
06/18/1997EP0779284A1 Novel 2-naphthamide derivatives and their use in therapy as D3 receptor agonists
06/17/1997US5639775 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof
06/17/1997US5639760 Useful as muscle relaxants, sedatives, anxiolytics, anticonvulsants, and antidotes for drug overdose
06/12/1997WO1997020569A2 Bioartificial devices and cellular matrices therefor
06/11/1997EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals
06/11/1997CN1151760A Serum paraoxonase
06/05/1997CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant
06/04/1997EP0776323A1 Salts of an anti-migraine indole derivative
05/1997
05/29/1997WO1997019054A1 Azulenyl nitrone spin trapping agents, methods of making and using same
05/28/1997EP0775485A1 New dosage form of hydroxocobalamin and its use in cyanide poisoning
05/28/1997EP0775143A1 New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
05/27/1997US5633382 Histamine H3 -receptor antagonists and therapeutic uses thereof
05/27/1997US5633238 Method for the treatment of schizophrenia
05/21/1997CN1150428A Corticotropin releasing factor antagonists
05/14/1997EP0773221A1 Stable crystalline tetrahydrofolic acid salts
05/14/1997EP0772615A1 IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
05/14/1997CN1149588A Cyclic bonding inhibitor
05/13/1997US5629336 Use of glycine/NMDA receptor ligands for the treatment of drug dependence and withdrawal
05/13/1997US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor
05/13/1997US5629193 Paraoxonase
05/09/1997WO1997016532A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx
05/07/1997CN1149295A Tricyclic Dicarbonyl derivatives
05/07/1997CN1148979A Complete Chinese medical preparation for chronic fatigue syndrome and process thereof
05/02/1997EP0770622A2 Cyclic adhesion inhibitors
05/02/1997EP0770081A1 Heterocycle-condensed morphinoid derivatives
05/02/1997EP0769956A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
05/01/1997WO1997015323A1 Infusions of neuroprotectants and thrombolytic agents
04/1997
04/30/1997CN1148807A Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments
04/29/1997US5625085 Immunology
04/17/1997WO1997013521A1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves
04/16/1997EP0767665A1 Protective prostaglandins for use in conjunction with chemotherapeutic agents
04/15/1997US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain
04/15/1997US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases
04/09/1997EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
04/08/1997US5618817 Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders
04/08/1997US5618812 Benzodiazepine derivatives
04/03/1997WO1996038473A3 Antimicrobial cationic peptides
04/02/1997EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same
03/1997
03/26/1997EP0764166A1 Corticotropin releasing factor antagonists
03/26/1997EP0764027A1 Method for protection against genotoxic mutagenesis